Alexander Stein

7.7k total citations · 1 hit paper
165 papers, 3.0k citations indexed

About

Alexander Stein is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Alexander Stein has authored 165 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Oncology, 72 papers in Pulmonary and Respiratory Medicine and 45 papers in Surgery. Recurrent topics in Alexander Stein's work include Colorectal Cancer Treatments and Studies (76 papers), Gastric Cancer Management and Outcomes (48 papers) and Cancer Treatment and Pharmacology (27 papers). Alexander Stein is often cited by papers focused on Colorectal Cancer Treatments and Studies (76 papers), Gastric Cancer Management and Outcomes (48 papers) and Cancer Treatment and Pharmacology (27 papers). Alexander Stein collaborates with scholars based in Germany, France and United States. Alexander Stein's co-authors include Wieland Voigt, Karin Jordan, Dirk Arnold, Hans‐Joachim Schmoll, Carsten Bokemeyer, Gerald W. Prager, Zev A. Wainberg, Joseph Tintelnot, Vivek Subbiah and Paul Burgess and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Alexander Stein

154 papers receiving 2.9k citations

Hit Papers

Dabrafenib plus trametinib in patients with BRAFV600E-mut... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
    2020 314 citations Vivek Subbiah, Antoîne Italiano et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Stein Germany 28 1.9k 972 832 542 422 165 3.0k
Ganessan Kichenadasse Australia 30 1.9k 1.0× 1.1k 1.2× 499 0.6× 612 1.1× 359 0.9× 168 3.4k
Desmond Yip Australia 30 1.6k 0.9× 938 1.0× 498 0.6× 579 1.1× 346 0.8× 162 2.9k
Myung Ah Lee South Korea 30 2.0k 1.1× 771 0.8× 1.2k 1.5× 569 1.0× 288 0.7× 156 3.5k
Monika Klinkhammer‐Schalke Germany 27 1.4k 0.7× 552 0.6× 616 0.7× 567 1.0× 372 0.9× 171 2.9k
Noelle K. LoConte United States 25 2.1k 1.1× 579 0.6× 771 0.9× 478 0.9× 671 1.6× 130 3.4k
Hei‐Cheul Jeung South Korea 31 1.2k 0.6× 1.2k 1.2× 687 0.8× 868 1.6× 200 0.5× 138 2.8k
Thomas Ruhstaller Switzerland 29 1.7k 0.9× 949 1.0× 802 1.0× 270 0.5× 199 0.5× 85 2.9k
Alessandro Passardi Italy 23 1.5k 0.8× 488 0.5× 390 0.5× 497 0.9× 308 0.7× 138 2.2k
Frans Erdkamp Netherlands 26 2.7k 1.4× 1.3k 1.3× 377 0.5× 572 1.1× 587 1.4× 82 3.7k
Yuanyuan Zhao China 29 1.9k 1.0× 1.1k 1.1× 475 0.6× 558 1.0× 257 0.6× 162 3.0k

Countries citing papers authored by Alexander Stein

Since Specialization
Citations

This map shows the geographic impact of Alexander Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Stein more than expected).

Fields of papers citing papers by Alexander Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Stein. The network helps show where Alexander Stein may publish in the future.

Co-authorship network of co-authors of Alexander Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Stein. A scholar is included among the top collaborators of Alexander Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Stein. Alexander Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hecht, J. Randolph, Young Suk Park, Josep Tabernero, et al.. (2025). Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial. The Lancet. 406(10517). 2360–2370. 3 indexed citations
3.
Paschold, Lisa, Christoph Schultheiß, Konrad Klinghammer, et al.. (2025). Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer. npj Precision Oncology. 9(1). 272–272.
4.
5.
Rothkamm, Kai, Thorsten Rieckmann, Michael Horn, et al.. (2020). Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays. Cancer Letters. 493. 179–188. 10 indexed citations
6.
7.
Folprecht, Gunnar, Alexander Stein, Michael Stahl, et al.. (2020). Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP. British Journal of Cancer. 124(4). 721–727. 3 indexed citations
8.
Stein, Alexander & Gunnar Folprecht. (2018). Immunotherapy of Colon Cancer. Oncology Research and Treatment. 41(5). 282–285. 31 indexed citations
9.
10.
Keam, Bhumsuk, Robert J. Kreitman, Zev A. Wainberg, et al.. (2018). Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E–mutated anaplastic thyroid cancer (ATC). Annals of Oncology. 29. viii645–viii646. 11 indexed citations
11.
Schmoll, Hans‐Joachim, Benjamin Garlipp, Christian Junghanß, et al.. (2017). FOLFOX/Bevacizumab +/− Irinotecan in advanced colorectal cancer (AIO) “CHARTA”: Final results and multivariate prognostic factor analysis. Annals of Oncology. 28. iii152–iii152. 1 indexed citations
12.
Suling, Anna, Karin Oechsle, Anja Mehnert, et al.. (2016). Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study. BMC Palliative Care. 15(1). 25–25. 9 indexed citations
13.
Folprecht, Gunnar, Philip Beer, Ramón Salazar, et al.. (2016). Frequency of potentially actionable genetic alterations in EORTC SPECTAcolor. Annals of Oncology. 27. vi151–vi151. 1 indexed citations
14.
Blau, Gary, et al.. (2015). Exploring Primary Referral Source Impact on Student Initial Perceptions of Counseling.. College student journal. 49(1). 41–48. 1 indexed citations
15.
Blau, Gary, et al.. (2015). Wait Time for Counseling Affecting Perceived Stigma and Attitude toward the University. College student journal. 49(2). 280–290. 4 indexed citations
16.
Loupakis, Fotios, Alexander Stein, Marc Ychou, et al.. (2015). A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer. Targeted Oncology. 11(3). 293–308. 22 indexed citations
17.
Stein, Alexander, Volker Petersen, Jörg Seraphin, et al.. (2014). Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study. Acta Oncologica. 54(2). 171–178. 12 indexed citations
18.
Stein, Alexander. (2014). How to select the optimal treatment for first line metastatic colorectal cancer. World Journal of Gastroenterology. 20(4). 899–899. 25 indexed citations
19.
Attig, Sebastian, Cedrik M. Britten, Henning Schulze‐Bergkamen, et al.. (2014). Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction. Cancer Immunology Immunotherapy. 63(12). 1273–1284. 1 indexed citations
20.
Arnold, Dirk & Alexander Stein. (2012). Personalized Treatment of Colorectal Cancer. Onkologie. 35(s1). 42–48. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ganessan Kichenadasse Breakdown of academic impact, for papers by Desmond Yip Breakdown of academic impact, for papers by Myung Ah Lee Breakdown of academic impact, for papers by Monika Klinkhammer‐Schalke Breakdown of academic impact, for papers by Noelle K. LoConte Breakdown of academic impact, for papers by Hei‐Cheul Jeung Breakdown of academic impact, for papers by Thomas Ruhstaller Breakdown of academic impact, for papers by Alessandro Passardi Breakdown of academic impact, for papers by Frans Erdkamp Breakdown of academic impact, for papers by Yuanyuan Zhao
Rankless by CCL
2026